S.C.Pharmaceuticals Private Limited
About S.C.Pharmaceuticals Private Limited
Data last updated:
S.C.Pharmaceuticals Private Limited is a private limited company based in West Bengal, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 10 January 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24231WB1997PTC082561. Its GSTIN is 19AAHCS1181Q1ZP (West Bengal). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Debal Chandra Das and Sipra Das.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nagdaha Kanpa 24 – Parganas, West Bengal, India.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.13 Lakh, a decline of 16% compared to the previous year. For the same year it recorded a net profit of ₹92,303 (net margin 5.4%) and EBITDA of ₹1.26 Lakh (EBITDA margin 7.3%). Revenue has declined at a compounded annual rate (CAGR) of 7% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
S.C.Pharmaceuticals Private Limited's registered office is in West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNagdaha Kanpa 24 – Parganas, West Bengal, India
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of S.C.Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of S.C.Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of S.C.Pharmaceuticals Private Limited, buy the company report.
Financials of S.C.Pharmaceuticals Private Limited
FY 2025 filings availableS.C.Pharmaceuticals Private Limited reported revenue of ₹17.13 Lakh (down 16% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 7% over three years, including a 16% fall in the latest year. EBITDA rose 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.26 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹92,303 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.3% | ||||
| Net Profit Margin | 5.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of S.C.Pharmaceuticals Private Limited, buy the company report.
Board of directors of S.C.Pharmaceuticals Private Limited
S.C.Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Debal Chandra Das | Director | 10 Jan 1997 | 29 Years 9 Months | Current |
| Sipra Das | Director | 10 Jan 1997 | 29 Years 9 Months | Current |
Peer comparison
S.C.Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Unither Laboratories Private Limited | ₹17.16 Lakh (FY 2018) | 24.0% | Darbhanga, Bihar, India | |||
| Orako Foods Private Limited | ₹17.16 Lakh (FY 2024) | 78.0% | Kollam, Kerala, India | |||
| Malpro Silica Private Limited | ₹17.16 Lakh (FY 2019) | 138.0% | Tamil Nadu, India | |||
| Kwot Healthcare Private Limited | ₹17.15 Lakh (FY 2024) | -52.0% | Vadodara, Gujarat, India | |||
| Msshine Private Limited | ₹17.14 Lakh (FY 2022) | 441.0% | Ahmedabad, Gujarat, India | |||
| S.C.Pharmaceuticals Private Limitedthis company | ₹17.13 Lakh (FY 2024) | ₹92,303 | 5.4% | -16.0% | West Bengal, India | |
| Aprameya Chemical & Rubber Private Limited | ₹17.13 Lakh (FY 2024) | 1611.0% | Anklesver, Gujarat, India | |||
| Metsun Pharma India Private Limited | ₹17.11 Lakh (FY 2018) | Aurangabad, Maharashtra, India | ||||
| Xenon Laboratories Private Limited | ₹17.1 Lakh (FY 2025) | 14.0% | Chandigarh, India | |||
| Aries Micro Nutrients (India) Private Limited | ₹17.09 Lakh (FY 2025) | -35.0% | Hyderabad, Telangana, India | |||
| V.R.Surgiplast Private Limited | ₹17.09 Lakh (FY 2015) | 156.0% | Gwalior, Madhya Pradesh, India |
To see the full peer comparison of S.C.Pharmaceuticals Private Limited, buy the company report.
Auditor
S.C.Pharmaceuticals Private Limited is audited by C.DAS & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C.DAS & CO | FY 2017 | 307167E |
Shareholding
The shareholding of S.C.Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of S.C.Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving S.C.Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for S.C.Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
S.C.Pharmaceuticals has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAHCS1181Q1ZP | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of S.C.Pharmaceuticals Private Limited, buy the company report.
Recent activity
S.C.Pharmaceuticals Private Limited has 3 board changes on record since 1997: 2 appointments and 1 cessation. The latest: Malin Chandra Das ceased to be Director on 01 Jun 2019.
Frequently asked questions
S.C.Pharmaceuticals is an active private limited company based in West Bengal, India. The company works in other wholesale, within the trading industry. It was incorporated on 10 January 1997 (29+ years old) and is registered under CIN U24231WB1997PTC082561.
S.C.Pharmaceuticals has 2 current directors:
- Debal Chandra Das - Director
- Sipra Das - Director
The latest financial statements of S.C.Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of S.C.Pharmaceuticals is 19AAHCS1181Q1ZP, registered in West Bengal. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of S.C.Pharmaceuticals is U24231WB1997PTC082561. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
S.C.Pharmaceuticals was incorporated on 10 January 1997, making it 29+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of S.C.Pharmaceuticals by revenue are Unither Laboratories Private Limited, Orako Foods Private Limited, Malpro Silica Private Limited, Kwot Healthcare Private Limited, Msshine Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Malin Chandra Das ceased to be Director on 01 Jun 2019. Debal Chandra Das was appointed as Director on 10 Jan 1997. Sipra Das was appointed as Director on 10 Jan 1997.
The registered office of S.C.Pharmaceuticals is at Nagdaha Kanpa 24 – Parganas, West Bengal, India.
S.C.Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of S.C.Pharmaceuticals is compliant as of 10 August 2026. The company is actively filing with the Registrar of Companies.